Search - tctmd.com

Displaying 301 - 311 of 311

Sort: Relevancy | Date

News Daily News

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

L.A. McKeown

October 28, 2011

News Industry News

The PROTEUS™ Device Combines Balloon Angioplasty and Embolic Capture of Particles

September 08, 2011

News Industry News

BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study

August 03, 2011

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

News Daily News

OAT Fails to Change Practice: No Decrease in Late PCI for Stable MI Patients

L.A. McKeown

July 12, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

Unique Approach Helps Breach Chronic Total Occlusions in FIM Trial

Jason Kahn

May 18, 2011

News Industry News

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

March 28, 2011

News Industry News

Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions

February 14, 2011

News Industry News

Advertisement

Extended OAT Follow-up: Still No Clinical Advantage for Late Stenting

The PROTEUS™ Device Combines Balloon Angioplasty and Embolic Capture of Particles

BridgePoint Medical Announces US IDE Approval and First Patient Enrollment of Peripheral Chronic Total Occlusion Study

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

OAT Fails to Change Practice: No Decrease in Late PCI for Stable MI Patients

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Unique Approach Helps Breach Chronic Total Occlusions in FIM Trial

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content